QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2020, 卷号: 9 作者:  Zhou, Qinfei;  Zhao, Jiazheng;  Wang, Jie;  Bao, Guanai;  Gong, Li-Yan 收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26 Small-cell lung cancer (SCLC)  immunotherapy  durvalumab  third-line treatment  case report   Combined effects of gallic acid and propolis on beryllium-induced hepatorenal toxicity 期刊论文 INTEGRATIVE ZOOLOGY, 2008, 卷号: 3, 期号: 3, 页码: 194-207 作者:  Nirala, SK;  Li, PQ;  Bhadauria, M;  Guo, GQ 收藏  |  浏览/下载：3/0  |  提交时间：2015/12/11 beryllium toxicity  gallic acid  3,4,5-trihydroxy benzoic acid  hepatorenal dysfunction  propolis   Attenuation of beryllium induced hepatorenal dysfunction and oxidative stress in rodents by combined effect of gallic acid and piperine 期刊论文 ARCHIVES OF PHARMACAL RESEARCH, 2007, 卷号: 30, 期号: 12, 页码: 1575-1583 作者:  Zhao, JQ;  Du, GZ;  Xiong, YC;  Wen, YF;  Bhadauria, M 收藏  |  浏览/下载：5/0  |  提交时间：2015/12/14 beryllium toxicity  gallic acid  3,4,5-trihydroxy benzoic acid  piperine  biochemical alterations  hepatorenal dysfunction  oxidative stress  combined therapy